# Continuity Biosciences, LLC

Canonical: https://abierto.us/vendors/continuity-biosciences-llc-ktr8ee8dbfx5

- UEI: KTR8EE8DBFX5
- CAGE: 13F55
- Location: Bradenton, FL
- Awards in window: 1 (3 transactions), $2,995,581 obligated, August 22, 2025 to August 18, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $2,995,581

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,995,581

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00024 (definitive contract): $2,995,581, NIH NCI. Direct to Phase II SBIR Concept Award for Novel Iontophoretic Drug Delivery Device for Local and Effective Treatment of Oral Cancer. https://www.usaspending.gov/award/CONT_AWD_75N91025C00024_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/continuity-biosciences-llc-ktr8ee8dbfx5.